Funder: Alliance for Cancer Gene Therapy
Due Dates: May 15, 2026 (Letter of Intent/Abstract, 11:00 am EST) | September 1, 2026 (Full application for invited applicants, 11:00 am EST)
Funding Amounts: Up to $500,000 total over 2–3 years, including up to 10% indirect costs.
Summary: Supports translational research developing innovative cell and gene therapy strategies to overcome barriers in treating solid tumor cancers.